BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26948202)

  • 1. Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
    Papageorgiou N; Zacharia E; Briasoulis A; Androulakis E; Tousoulis D
    Trends Cardiovasc Med; 2016 Jul; 26(5):433-41. PubMed ID: 26948202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and Secondary Prevention of Acute Coronary Syndromes: The Role of the Statins.
    Diamantis E; Troupis T; Mazarakis A; Kyriakos G; Diamanti S; Troupis G; Skandalakis P
    Recent Adv Cardiovasc Drug Discov; 2014; 9(2):97-105. PubMed ID: 26152179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.
    Miedema MD; Garberich RF; Schnaidt LJ; Peterson E; Strauss C; Sharkey S; Knickelbine T; Newell MC; Henry TD
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28404560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atorvastatin in the treatment of high risk patients with ischemic heart disease and dyslipidemia. Safety assessment in the Russian Multicenter Study ATLANTIKA].
    Mareev VIu
    Kardiologiia; 2010; 50(9):4-14. PubMed ID: 21118160
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 8. Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction.
    Booth JN; Colantonio LD; Rosenson RS; Safford MM; Chen L; Kilgore ML; Brown TM; Taylor B; Dent R; Monda KL; Muntner P; Levitan EB
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
    Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of preoperative oral pravastatin reload in systemic inflammatory response and myocardial damage after coronary artery bypass grafting. A pilot double-blind placebo-controlled study.
    Castaño M; González-Santos JM; López J; García B; Centeno JE; Aparicio B; Bueno MJ; Díez R; Sagredo V; Rodríguez JM; García-Criado FJ
    J Cardiovasc Surg (Torino); 2015 Aug; 56(4):617-29. PubMed ID: 25968407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.
    Virani SS
    Tex Heart Inst J; 2013; 40(3):288-9. PubMed ID: 23914021
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
    Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effects of atorvastatin on myocardial infarction.
    Barbarash O; Gruzdeva O; Uchasova E; Belik E; Dyleva Y; Karetnikova V
    Drug Des Devel Ther; 2015; 9():3361-8. PubMed ID: 26170622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet therapy for secondary prevention of coronary artery disease.
    Pilgrim T; Windecker S
    Heart; 2014 Nov; 100(22):1750-6. PubMed ID: 25037531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinitiation of statins after statin-associated musculoskeletal symptoms: a patient-centered approach.
    Brito JP; Montori VM
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):243-7. PubMed ID: 23481527
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Use in the Early Phase of ST-Segment Elevation Myocardial Infarction Is Associated With Decreased QTc Dispersion.
    Munhoz DB; Carvalho LSF; Venancio FNC; Rangel de Almeida OL; Quinaglia E Silva JC; Coelho-Filho OR; Nadruz W; Sposito AC
    J Cardiovasc Pharmacol Ther; 2020 May; 25(3):226-231. PubMed ID: 32008366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing statin treatment for primary prevention of coronary artery disease.
    Hayward RA; Krumholz HM; Zulman DM; Timbie JW; Vijan S
    Ann Intern Med; 2010 Jan; 152(2):69-77. PubMed ID: 20083825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.